Titan Biotech Limited (BOM:524717)
India flag India · Delayed Price · Currency is INR
366.40
+16.80 (4.81%)
At close: Nov 9, 2026

Titan Biotech Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
386.62298.85215.32248.53248.44216.84
Depreciation & Amortization
52.3449.0341.533.0425.7423.47
Other Amortization
0.220.220.20.270.270.22
Provision & Write-off of Bad Debts
3.633.63----
Other Operating Activities
16.5516.44-20.322.4-33.0713.18
Change in Accounts Receivable
14.95-46-0.9524.5-45.1920.32
Change in Inventory
-178.44-49.49-51.52-94.02-14.9-78.52
Change in Accounts Payable
27.38.8618.48-21.8213.8924.88
Change in Other Net Operating Assets
-0.6822.66-1.4718.5716.6-
Operating Cash Flow
322.48304.21201.23211.46211.78220.41
Operating Cash Flow Growth
55.03%51.17%-4.84%-0.15%-3.91%15.50%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-113.38-74.28-85.21-194.85-127.34-63.11
Sale of Property, Plant & Equipment
10.040.162.212.94-
Sale (Purchase) of Intangibles
---0.47-0.37-0.07-
Investment in Securities
-108.66-251.22-13.02-115.97-75.55-27.56
Other Investing Activities
3.68--105.94-7.24-73.69
Investing Cash Flow
-217.37-325.46-98.53-203.04-207.25-164.37

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-14.26-0.182.49-
Long-Term Debt Issued
-1.43-1.541.15-
Total Debt Issued
-39.4815.69-1.723.64-
Short-Term Debt Repaid
---48---9.91
Long-Term Debt Repaid
--5.27-7.28-3.81-7.82-9.96
Lease Payments
-8.22-5.27-4.59-3.81--2.5
Total Debt Repaid
-8.22-5.27-55.28-3.81-7.82-19.87
Net Debt Issued (Repaid)
-47.710.42-55.28-2.09-4.18-19.87
Common Dividends Paid
-20.66-16.53-16.53-14.88-12.4-12.4
Other Financing Activities
-9.73-9.14-8.02-11.7-7.46-8.72
Financing Cash Flow
-78.09-15.25-79.82-28.66-24.03-40.99

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-----0
Net Cash Flow
27.03-36.522.88-20.24-19.515.05

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
209.1229.93116.0316.6184.45157.29
Free Cash Flow Growth
45.80%98.16%598.38%-80.33%-46.31%-2.13%
Free Cash Flow Margin
8.68%11.15%7.42%1.01%5.86%12.73%
Free Cash Flow Per Share
4.504.452.250.321.643.04
Levered Free Cash Flow
91.31153.6868.63-46.2628.91107.87
Unlevered Free Cash Flow
95.37157.3671.38-41.2831.73111.62
Free Cash Flow After Leases
200.88224.65111.4412.884.45154.79

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
6.495.94.47.964.55.99
Cash Income Tax Paid
109.0485.4859.978.77571.18
Change in Working Capital
-136.87-63.97-35.46-72.77-29.6-33.31